ت:    25332330
نقال: 90094424
2:00 الى 6:00 مساءا (أيام الإسبوع)
السبت 10:30 ص-1:30 م. الجمعة عطلة

Large clinical trial will test combination monoclonal antibody therapy for mild/moderate COVID-19

05/01/2021

The Phase 2/3 clinical trial will evaluate experimental antibodies BRII-196 and BRII-198. 

Read More